Department of Food Science, University of Massachusetts, Amherst, Massachusetts 01003; email:
Annu Rev Food Sci Technol. 2014;5:53-81. doi: 10.1146/annurev-food-072913-100350. Epub 2013 Dec 11.
The oral bioavailability of lipophilic bioactive molecules can be greatly increased by encapsulating them within engineered lipid nanoparticles (ELNs), such as micelles, microemulsions, nanoemulsions, or solid lipid nanoparticles (SLNs). After ingestion, these ELNs are disassembled in the gastrointestinal tract (GIT) and then reassembled into biological lipid nanoparticles (mixed micelles) in the small intestine. These mixed micelles solubilize and transport lipophilic bioactive components to the epithelial cells. The mixed micelles are then disassembled and reassembled into yet another form of biological lipid nanoparticle [chylomicrons (CMs)] within the enterocyte cells. The CMs carry the bioactive components into the systemic (blood) circulation via the lymphatic system, thereby avoiding first-pass metabolism. This article provides an overview of the various physicochemical and physiological processes responsible for the assembly and disassembly of lipid nanoparticles outside and inside the GIT. This knowledge can be used to design food-grade delivery systems to improve the oral bioavailability of encapsulated lipophilic bioactive components.
亲脂性生物活性分子的口服生物利用度可以通过将其包封在工程化脂质纳米粒子(ELN)中而大大提高,例如胶束、微乳液、纳米乳液或固体脂质纳米粒子(SLN)。摄入后,这些 ELN 在胃肠道(GIT)中解体,然后在小肠中重新组装成生物脂质纳米粒子(混合胶束)。这些混合胶束溶解并将亲脂性生物活性成分输送到上皮细胞。然后,混合胶束在肠细胞内再次解体并重新组装成另一种形式的生物脂质纳米粒子[乳糜微粒(CM)]。CM 通过淋巴系统将生物活性成分携带到全身(血液)循环中,从而避免首过代谢。本文概述了负责 GIT 内外脂质纳米粒子组装和解体的各种物理化学和生理过程。这些知识可用于设计食品级递送系统以提高包封亲脂性生物活性成分的口服生物利用度。